Editas Medicine (EDIT) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to -$1000.0.
- Editas Medicine's Other Non Operating Income rose 8000.0% to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year decrease of 1552142.86%. This contributed to the annual value of -$3000.0 for FY2024, which is 9981.3% up from last year.
- According to the latest figures from Q3 2025, Editas Medicine's Other Non Operating Income is -$1000.0, which was up 8000.0% from -$1.8 million recorded in Q2 2025.
- Editas Medicine's Other Non Operating Income's 5-year high stood at $235000.0 during Q2 2022, with a 5-year trough of -$1.8 million in Q2 2025.
- Moreover, its 5-year median value for Other Non Operating Income was -$2000.0 (2021), whereas its average is -$208666.7.
- Per our database at Business Quant, Editas Medicine's Other Non Operating Income soared by 2360000.0% in 2022 and then tumbled by 17570000.0% in 2025.
- Quarter analysis of 5 years shows Editas Medicine's Other Non Operating Income stood at -$1000.0 in 2021, then crashed by 300.0% to -$4000.0 in 2022, then crashed by 250.0% to -$14000.0 in 2023, then skyrocketed by 78.57% to -$3000.0 in 2024, then soared by 66.67% to -$1000.0 in 2025.
- Its Other Non Operating Income stands at -$1000.0 for Q3 2025, versus -$1.8 million for Q2 2025 and -$425000.0 for Q1 2025.